08/01/2008
Imad Sheiban, MD; Giuseppe G.L. Biondi-Zoccai, MD, PhD; Amedeo Chiribiri, MBBS, PhD, FHEA; Claudio Moretti, MD; Serena Beninati, MD; Pierluigi Omedè, MD; Filippo Sciuto, MD; Walter Grosso Marra, MD; Alfonso Gambino, MD; Mario Bollati, MD; Gian Paolo Trevi, MD
Significant in-stent restenosis (ISR), i.e., intrastent neo-intimal proliferation following bare-metal stent (BMS) implantation, which determines an angiographic and/or clinically significant stenosis,1 occurs with an incidence varying...
Significant in-stent restenosis (ISR), i.e., intrastent neo-intimal proliferation following bare-metal stent (BMS) implantation, which determines an angiographic and/or clinically significant stenosis,1 occurs with an incidence varying...
Significant in-stent restenosis...